EVERSANA Announces Launch of ACTICS
A technology-enabled solution combining predictive analytics integrated with real-time commercial services for the life sciences sector.
EVERSANA today launched ACTICS by EVERSANA, a technology-enabled solution to optimize end-to-end commercial success for life science companies. Combining the power of AI-driven predictive analytics with ready-to-deploy, real-time commercial services, ACTICS provides a cloud-based solution for pharmaceutical innovators to optimize actions in the product and patient journeys.
ACTICS is built on a data-mastering platform and cloud-based infrastructure, enabling the ability to combine multiple data sources into a comprehensive and actionable system. Through API-driven automated intelligence and machine learning technology, ACTICS feeds downstream alerts to additional cloud-based infrastructure, such as a client’s CRM system, to create actionable insights.
ACTICS can also solve specific commercial challenges, such as optimizing market access, evidence creation or patient-finding barriers. Clients can leverage select ACTICS capabilities, including project-based data science services, data accessibility and platform licenses for subscription-based modules and platform applications.
For more information, click here.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Beyond the Prescription: The Role Pharma Plays in Digital Health Conversations
April 1st 2025As social media continues to influence healthcare communication, it presents both challenges and opportunities for the pharmaceutical industry. In this interview, Jennifer Harakal of Canopy Life Sciences discusses balancing compliance with effective digital engagement to build trust and facilitate meaningful healthcare conversations.
